In a strategic move, ASA has hired Vince Loffredo, Ed.D., as its new Chief Learning Officer, where he will oversee the Education, Meetings, and Publications departments, as well as serve as a vital member of ASA’s CEO team.
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide—and that number is only growing larger.
A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.
In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to “raise its persuasive communications game” on adult immunization to clinicians and the public.
Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.
Not for public release
This news release is embargoed until 11-Jan-2024 1:00 PM EST
Released to reporters: 4-Jan-2024 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 11-Jan-2024 1:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and insurance status.
The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.
Federal officials are describing a ‘tripledemic’ of respiratory infections on the rise. Flu, COVID-19, and RSV are spiking, as expected, as we are in the mid-winter months. Lisa M. Lee, a professor of public health at Virginia Tech, answered questions about factors for concern and the importance of vaccination. Lee is an epidemiologist and bioethicist who has worked in public health and ethics for 25 years, including 14 years with CDC.
Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.
Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.
A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.
In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase
Not for public release
This news release is embargoed until 8-Jan-2024 5:00 PM EST
Released to reporters: 2-Jan-2024 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 8-Jan-2024 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Not for public release
This news release is embargoed until 8-Jan-2024 5:00 PM EST
Released to reporters: 2-Jan-2024 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 8-Jan-2024 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.
A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.In a new paper in the journal Acta Biomaterialia, Professor William Murphy and collaborators in his lab detail how using an optimized mineral coating composition can maintain mRNA activity for up to six months at room temperature.
New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.
Findings published in the journal Nature by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.
With virus cases rising and the holidays nigh, three expert from University of Michigan Health give their top 12 tips for avoiding or reducing the impact of COVID-19, flu, RSV, pneumonia and whooping cough in adults and kids.
The new study is among the first to quantify unmet demand for the vaccine — people who would be willing to be vaccinated if they had access.
Not for public release
This news release is embargoed until 11-Dec-2023 5:00 PM EST
Released to reporters: 5-Dec-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 11-Dec-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
According to new predictions by La Jolla Institute for Immunology (LJI) researchers, if the new SARS-CoV-2 Pirola variant wants to evade T cells, it isn't doing a very good job.
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics.
With the holiday season underway, and families and friends gathering to celebrate, a leading Cedars-Sinai Guerin Children’s pediatrician has one word of advice for parents: Vaccinate.
Darcy Dunn-Lawless, a doctoral student at the University of Oxford, is investigating the potential of a painless, needle-free vaccine delivery by ultrasound. The method uses cavitation, which is the formation and popping of bubbles in response to a sound wave. Though initial in vivo tests reported 700 times fewer vaccine molecules were delivered by the cavitation approach compared to conventional injection, the cavitation approach produced a higher immune response. The researchers theorize this could be due to the immune-rich skin the ultrasonic delivery targets. The result is a more efficient vaccine that could help reduce costs and increase efficacy.
In a paper published in The Journal of Infectious Diseases, Daniel Hoft, M.D., Ph.D., director of the Saint Louis University Center for Vaccine Development, and colleagues report a promising new approach to speed vaccine testing for TB.
Press conferences for Acoustics 2023 Sydney will be held virtually at 8:00 a.m. AEDT, Dec. 6 and Dec. 7. Topics will focus on a wide range of newsworthy sessions from the upcoming meeting, which runs Dec. 4-8 in Sydney, Australia.
During the first two years of the pandemic, a COVID-19 infection during pregnancy increased the risk of preterm birth and NICU hospitalizations.
Not for public release
This news release is embargoed until 27-Nov-2023 5:00 PM EST
Released to reporters: 20-Nov-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 27-Nov-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.
Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.
An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.
Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.